<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03194100</url>
  </required_header>
  <id_info>
    <org_study_id>METRNL</org_study_id>
    <nct_id>NCT03194100</nct_id>
  </id_info>
  <brief_title>Serum METRNL Concentration in Type 2 Diabetes</brief_title>
  <official_title>Comparison of Serum METRNL Concentration Between Type 2 Diabetes and Normal Glucose Tolerance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chungnam National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chungnam National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators measured serum METRNL levels in newly diagnosed patients with type 2
      diabetes (T2DM) compared with normal glucose tolerance or prediabetes and explored the
      correlations between its serum levels and various metabolic parameters
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Actual">November 30, 2016</completion_date>
  <primary_completion_date type="Actual">November 30, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>serum METRNL concentration</measure>
    <time_frame>on the 1 day of oral glucose tolerance test</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">125</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Diabetes Mellitus</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Prediabetes</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal glucose tolerance</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Oral glucose tolerance test (OGTT) was performed in all of the included participants. The
        participants were divided into three groups according to the American Diabetes Association
        criteria; normal glucose tolerance, prediabetes and diabetes mellitus.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who have not been diagnosed diabetes mellitus

        Exclusion Criteria:

          -  Person with diabetes who were treated with oral hypoglycemic agent or insulin

          -  Individuals with type 1 diabetes, gestational diabetes, active hepatitis/liver
             cirrhosis, chronic renal failure on hemodialysis, congestive heart failure, or other
             known major disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2017</study_first_submitted>
  <study_first_submitted_qc>June 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2017</study_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chungnam National University Hospital</investigator_affiliation>
    <investigator_full_name>Bon Jeong Ku</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

